195 related articles for article (PubMed ID: 25691619)
1. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
[TBL] [Abstract][Full Text] [Related]
2. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.
Li H; Yu X; Cicala MV; Mantero F; Benbrook A; Veitla V; Cunningham MW; Kem DC
J Am Soc Hypertens; 2015 Jan; 9(1):15-20. PubMed ID: 25537460
[TBL] [Abstract][Full Text] [Related]
5. A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.
Li H; Zhang L; Huang B; Veitla V; Scherlag BJ; Cunningham MW; Aston CE; Kem DC; Yu X
J Interv Card Electrophysiol; 2015 Dec; 44(3):205-12. PubMed ID: 26446828
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
[TBL] [Abstract][Full Text] [Related]
7. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
Zhang S; Zheng R; Yang L; Zhang X; Zuo L; Yang X; Bai K; Song L; Tian J; Yang J; Liu H
J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
Hong K; Li M; Nourian Z; Meininger GA; Hill MA
Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
[TBL] [Abstract][Full Text] [Related]
10. GnRH receptor-activating autoantibodies in polycystic ovary syndrome: identification of functional epitopes and development of epitope mimetic inhibitors.
Li H; Guo Y; Deng J; Gali H; Weedin EA; Burks HR; Craig LB; Yu X
Endocrine; 2022 Mar; 75(3):959-963. PubMed ID: 34807394
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
12. Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
Williams TA; Jaquin D; Burrello J; Philippe A; Yang Y; Rank P; Nirschl N; Sturm L; Hübener C; Dragun D; Bidlingmaier M; Beuschlein F; Reincke M
Hypertension; 2019 Oct; 74(4):784-792. PubMed ID: 31476909
[TBL] [Abstract][Full Text] [Related]
13. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers.
Singh KD; Jara ZP; Harford T; Saha PP; Pardhi TR; Desnoyer R; Karnik SS
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34380734
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
15. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
16. [Effect of losartan on produce of sera autoantibodies to angiotensin II-1 receptor in renovascular hypertension rats].
Zhi JM; Liu ZB; Jiao XY; Liu YX; Zhao RR
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):43-6. PubMed ID: 21207854
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta.
Zhang W; Zheng Y; Liu F; Wang X; Jin Z; Zhi J
Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):851-6. PubMed ID: 26350097
[TBL] [Abstract][Full Text] [Related]
18. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
19. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.
You D; Loufrani L; Baron C; Levy BI; Widdop RE; Henrion D
Circulation; 2005 Mar; 111(8):1006-11. PubMed ID: 15710752
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
